-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IqnqWiyzjJww4bzdD9F8YOczL/NOJ+smm/4uVeXu0ws5svFlGFoPmgOEOiuXalGT s0fA1TmdnJJbOXq2x+lwfA== 0000874015-08-000046.txt : 20080813 0000874015-08-000046.hdr.sgml : 20080813 20080813184913 ACCESSION NUMBER: 0000874015-08-000046 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080811 FILED AS OF DATE: 20080813 DATE AS OF CHANGE: 20080813 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Treble Michael J CENTRAL INDEX KEY: 0001311748 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 081014910 BUSINESS ADDRESS: BUSINESS PHONE: 760-931-9200 MAIL ADDRESS: STREET 1: ISIS PHARMACEUTICALS, INC. STREET 2: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2008-08-11 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001311748 Treble Michael J C/O ISIS PHARMACEUTICALS, INC. 1896 RUTHERFORD ROAD CARLSBAD CA 92008 0 1 0 0 Vice President, Pres of Ibis Common Stock 2008-08-11 2008-08-11 4 M 0 20000 5.95 A 20000 D Common Stock 2008-08-11 2008-08-11 4 S 0 10000 17.956 D 10000 D Common Stock 2008-08-11 2008-08-11 4 S 0 10000 18.95 D 0 D Employee Stock Option (right to buy) 5.95 2008-08-11 2008-08-11 4 M 0 20000 0 D 2005-12-06 2011-12-05 Common Stock 20000 32500 D The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 1/31/08. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 1/31/08. Grant of 12/6/04 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option will vest and become exercisable on 12/6/05. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 22,500 shares per year. The option was exercisable as to 52,500 shares on 8/11/08. /s/B. Lynne Parshall 2008-08-13 -----END PRIVACY-ENHANCED MESSAGE-----